Related Experiment Video
Updated: Jun 13, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
Published on: October 10, 2025
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy
Gian Paolo Fadini1, Enzo Manzato, Cristina Crepaldi
1Department of Clinical and Experimental Medicine, University of Padova, Medical School, Padova, Italy. gianpaolofadini@hotmail.com
Abstract:
HMG-CoA reductase inhibitors (statins) are highly effective drugs for prevention of cardiovascular events in high-risk patients. Due to the widespread prescription of these agents, special attention should be given to their rare adverse effects when these may have severe outcomes. Here, we report two cases of localized rhabdomyolysis associated with mononeuropathy in patients taking statins and suggest possible explanations for this uncommon association. Close monitoring for myopathic/neuropathic events is warranted in high-risk patients with pre-existing neuropathies who are taking statins.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Myasthenia Gravis ll: Pathophysiology
Nephrotic Syndrome I : Introduction
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Diabetic Neuropathy
Nephrotic Syndrome II : Assessment and Medical Management